Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
HOWL: Werewolf Therapeutics, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
HOWL
The Story
HOWL
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-100.0% / yr
Operating margin
-128.3%
ROIC
-165.4%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
-7.5×
Current ratio
2.91×
Werewolf Therapeutics, Inc.
HOWL
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Werewolf Therapeutics, Inc.
HOWL
NASDAQ
·
USD
·
Closed
$0.35
−29.44%
$0.35
−$0.15 (29.44%)
52W Range
4th
pctl
Volume
3.90×
avg
Mkt Cap
17.16M
USD
P/E
-0.5
TTM
Div Yield
–
ann
52W Range
4th
pctl
Volume
3.90×
avg
Market Cap
17.16M
USD
P/E Ratio
-0.5
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings